THIS IS A PUBLIC ANNOUNCEMENT FOR INFORMATION PURPOSES ONLY AND IS NOT A PROSPECTUS ANNOUNCEMENT. THIS DOES NOT CONSTITUTE AN INVITATION OR OFFER TO ACQUIRE, PURCHASE OR SUBSCRIBE TO SECURITIES. THIS PUBLIC ANNOUNCEMENT IS NOT INTENDED FOR PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY OUTSIDE INDIA.

AMKAY PRODUCTS LIMITED

Our Company was originally incorporated as "Amkay Products Private Limited" on October 25,2007 under the provisions of the Companies Act, 1956 with the Registrar of Companies, Maharashtra, Mumbai with CIN U51397MH2007PLC1754003. passed by the Shareholders at the Extra Ordinary General Meeting, held on August 02,2023, our Company was converted into a Public Limited Company and consequently the name of our Company was changed from "Amkay Products Private Limited" to "Amkay Product Limited" vide a fresh certificate of incorporation consequent upon conversion from private company to public company dated August 28,2023, issued by the Registrar of Companies, Maharashtra, Mumbai bearing CIN U51397MH2007PLC1754003

We are engaged in business of manufacture, assemble & market a comprehensive portfolio of medical devices, disposables and other Healthcare Products like Face Mask, Alcohol Swabs, Lancet Needles, Nebulizer, Pulse Oximeter, surgeon cap etc.

INITIAL PUBLIC OFFER OF 22,92,000 EQUITY SHARES OF FACE VALUE OF Rs. 10/- EACH (THE "EQUITY SHARES") OF AMKAY PRODUCTS LIMITED ("OUR COMPANY" OR "THE ISSUER") AT AN ISSUE PRICE OF Rs. 55 PER EQUITY SHARE (INCLUDING SHARE PREMIUM OF 45 PER EQUITY SHARE) FOR CASH, AGGREGATING UP TO Rs.1260.60 LAKHS ("PUBLIC ISSUE") OUT OF WHICH 1,20,000 EQUITY SHARES OF FACE VALUE OF Rs. 10 EACH, AT AN ISSUE PRICE OF Rs. 55 PER EQUITY SHARE FOR CASH, AGGREGATING Rs.66.00 LAKHS WILL BE RESERVED FOR SUBSCRIPTION BY THE MARKET MAKER TO THE ISSUE (THE "MARKET MAKER RESERVATION PORTION"). THE PUBLIC ISSUE LESS MARKET MAKER RESERVATION PORTION I.E. ISSUE OF 21,72,000 EQUITY SHARES OF FACE VALUE OF Rs. 10 EACH, AT AN ISSUE PRICE OF Rs. 55 PER EQUITY SHARE FOR CASH, AGGREGATING Rs.1194.60 LAKHS IS HEREIN AFTER REFERRED TO AS THE "NET ISSUE". THE PUBLIC ISSUE AND NET ISSUE WILL CONSTITUTE 26.48% AND 25.09% RESPECTIVELY OF THE POST- ISSUE PAID-UP EQUITY SHARE CAPITAL OF OUR COMPANY.

a) We generate our major portion of revenue from certain geographical regions and any adverse developments affecting our operations in these regions could have an adverse impact on our revenue and results of operations.

b) We depend on third parties to manufacture some of our products. If these organizations are unable or unwilling to manufacture our products, or if these organizations fail to comply with other applicable regulations or otherwise fail to meet our requirements, will adversely affect our business.

c) The Merchant Banker associated with the Issue has handled 43 public issues in the past three years out of which 2 Issue closed below the Issue Price on listing date.

d) Average cost of acquisition of Equity Shares held by the Individual Promoter is

and the Issue Price at the upper end of the Price Band is Rs. 55 per Equity Share.

e) The Price/ Earnings ratio based on Diluted EPS for Fiscal 2023 for the company at the upper end of the Price Band is 23.21

f) Weighted Average Return on Net worth for Fiscals 2023,2022 and 2021 is 28.66%

g) The Weighted average cost of acquisition of all Equity Shares transacted in the last one year, 18 months and three years from the date of RHP is as given below:

h) The Weighted average cost of acquisition compared to floor price and cap price

''There were no primary /new issue o f shares (equity/convertible securities) other than Equity Shares issued pursuant to a bonus issue on August 31, 2023 in last 18 months and three years p rio r to the date o f this Prospectus. AA There were no secondary sales /acquisition of shares of shares (equity/convertible securities) as mentioned in paragraph 8(a) above, in last 18 months from the date o f this Prospectus.

The Issue was being made through the Book Building Process, in term s of Rule 19(2)(b)(i) of the Securities Contracts (Regulation) Rules, 1957, as amended (" SCRR") read w ith Regulation 253 of the SEBI ICDR Regulations, as amended, wherein not more than 50% of the Net Issue was available for allocation on a proportionate basis to Qualified Institutional Buyers (" QIBs" , the " QIB Portion"), Our Company in consultation with the Book Running Lead Manager has allocated upto 60% of the QIB Portion to Anchor Investors on a discretionary basis in accordance w ith the SEBI ICDR Regulations ("Anchor Investor Portion" ). Further, not less than 15% of the Net Issue shall be available fo r allocation on a proportionate basis to Non-lnstitutional Bidders and not less than 35% of the Net Issue was made available fo r allocation to Retail Individual Bidders in accordance w ith the SEBI (ICDR) Regulations, subject to valid Bids being received at or above the Issue Price. All potential Bidders (except Anchor Investors) were required to mandatorily utilise the Application Supported by Blocked Amount ("ASBA" ) process providing details of their respective ASBA accounts, and UPI ID in case of RIBs using the UPI Mechanism, if applicable, in which the corresponding Bid Amounts w ill be blocked by the SCSBs or by the Sponsor Bank under the UPI Mechanism, as the case may be, to the extent of respective Bid Amounts. Anchor Investors were not permitted to participate in the Issue through the ASBA process. For details, see " Issue Procedure" beginning on page 222 of the Prospectus.

The investors are advised to refer to the Prospectus fo r the full text of the Disclaim er clause pertaining to BSE. For the purpose of this Issue, the Designated Stock Exchange w ill be the BSE Limited. The trading is proposed to be commenced on o r before Wednesday, May 08, 2024 *

*Subject to the receipt of listing and trading approval from the BSE (BSE SME).

The bidding for Anchor Investors opened and closed on Monday, April 29,2024. The Company received 2 Anchor Investors applications for 74,000 Equity Shares. The Anchor Investor Allocation price was finalized at Rs. 55/- per Equity Share. A total of 6,50,000 Equity Shares were allotted under the Anchor Investors portion aggregating to Rs. 3,57,50,000/-.

The Issue (excluding Anchor Investors Portion) received 4,00,549 Applications for 1,14,78,56,000 Equity Shares (after bid not banked cases and removing m ultiple and duplicate bids and before technical rejection) resulting 699.06 subscription (including reserved portion of market maker). The details of the Applications received in the Issue from various categories are as under:

Detail of the Applications Received (excluding Anchor Investors Portion and before technical rejections):

Final Demand:

A summary of the final demand as per BSE as on the Bid /Issue Closing Date at different Bid prices is as under:

The Basis of Allotment was finalized in consultation with the Designated Stock Exchange, being BSE Limited (BSE SME) on May 06,2024.

1) Allotment to Retail Individual Investors (After Technical Rejections):

The Basis of Allotment to the Retail Individual Investors, w ho have Bid at cut-off Price or at the Issue Price of Rs. 55 per Equity Share, was finalized in consultation w ith BSE. The category has been subscribed to the extent of 963.46 times (after technical rejections). The total number of Equity Shares Allotted in this category is 7,62,000 Equity Shares to 381 successful applicants. The details of the Basis of Allotment of the said category are as under:

2) Allotment to Non-lnstitutional Investors (After Technical Rejections):

The Basis of Allotm ent to the Non-lnstitutional Investors, w ho have bid at the Issue Price of Rs. 55 per Equity Share, was finalized in consultation w ith BSE. The category has been subscribed to the extent of 986.37 tim es. The total number of Equity Shares Allotted in this category is 3,26,000 Equity Shares to 163 successful applicants. The details of the Basis of Allotm ent of the said category are as under (Sample Basis):

3) Allotment to QIBs excluding Anchor Investors (After Technical Rejections):

Allotment to QIBs, w ho have bid at the Issue Price of Rs. 55 per Equity Share or above, has been done on a proportionate basis in consultation w ith BSE. This category has been subscribed to the extent of 167.39 tim es of QIB portion. The total num ber of Equity Shares allotted in the QIB category is 4,34,000 Equity Shares, which were allotted to 67 successful Applicants.

4) Allotment to Anchor Investors (After Technical Rejections):

The Company in consultation w ith the BRLM has allocated 6,50,000 Equity Shares to 2 Anchor Investors at the Anchor Investor Issue Price of Rs. 55 per Equity Shares in accordance w ith the SEBI (ICDR) Regulations. This represents upto 60% of the QIB Category.

The Board of Directors of our Company at its meeting held on May 06, 2024 has taken on record the basis of allotment of Equity Shares approved by the Designated Stock Exchange, being BSE and has allotted the Equity Shares to various successful applicants. The Allotment Advice Cum Refund Intimation w ill be dispatched to the address of the investors as registered with the depositories. Further, instructions to the SCSBs have been dispatched/ mailed for unblocking of funds and transfer to the Public Issue Account on o r before May 07, 2024. In case the same is not received within ten days, Investors may contact the Registrar to the Issue at the address given below. The Equity Shares allotted to the successful allottees shall be uploaded on May 0 7 ,2024 for credit into the respective beneficiary accounts subject to validation of the account details with the depositories concerned. The Company is in the process of obtaining the listing and trading approval from BSE and the trading of the Equity Shares is expected to commence trading on Wednesday, May 08,2024.

Note: All capitalized term s used and not defined herein shall have the respective meanings assigned to them in the Prospectus dated May 04, 2024 filed with the Registrar of Companies, Mumbai (" RoC" ).

The details of the allotment made has been hosted on the website of the Registrar to the Issue Bigshare Services Private Limited at website: www.bigshareonline.com

TRACK RECORD OF BOOK RUNNING LEAD MANAGERS: The Merchant Banker associated with the Issue has handled 43 public issues in the past three years out of which 2 Issue closed below the Issue Price on listing date.

All future correspondence in this regard may kindly be addressed to the Registrar to the Issue quoting full name of the First/ Sole Bidder Serial number of the ASBA form, number of Equity Shares bid for, Bidder DP ID, Client ID, PAN, date of submission of the Bid cum Application Form, address of the Bidder, the name and address of the Designated Intermediary where the Bid cum Application Form was submitted by the Bidder and copy of the Acknowledgment Slip received from the Designated Intermediary and payment details at the address given below:

	Bigshare Services Private Limited
	Address: S6-2,6th Floor, Pinnacle Business Park, Next to Ahura Centre, Mahakali Caves Road, Andheri (East) Mumbai - 400093, Maharashtra, India.
	Tel No: +91 22 6263 8200; Email: ipo@bigshareonline.com;
	Investor Grievance Email: investor@bigshareonline.com; Website: www.bigshareonline.com;
	Contact Person: Vinayak Morbale; SEBI Reg. No.: MB/INR000001385; CIN: U99999MH1994PTC076534

THE LEVEL OF SUBSCRIPTION SHOULD NOT BE TAKEN TO BE INDICATIVE OF EITHER THE MARKET PRICE OF THE EQUITY SHARES ON LISTING OR THE BUSINESS PROSPECTS OF AMKAY PRODUCTS LIMITED

Disclaimer: Amkay Products Limited has file d the Prospectus with the RoC on May 04, 2024 and thereafter with SEBI and the Stock Exchange. The Prospectus is available on the website o f the BRLMs, Hem Securities Limited at www.hemsecurities.com and the Company at: www.amkayproducts.com, and shall also be available on the website o f the BSE and SEBI. Investors should note that investment in Equity Shares involves a high degree of risk and for details relating to the same, please see "Risk Factors" beginning on page 25 o f the Prospectus. not be issued or sold within the United States, except pursuant to an exemption from, or in a transaction not "offshore transactions" in reliance on Regulation under the Securities Act and the applicable laws of each jurisdiction 3 public Issuing